ID: ALA164927

Max Phase: Preclinical

Molecular Formula: C10H15N5O2

Molecular Weight: 237.26

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(CO)OCn1cnc2c(N)ncnc21

Standard InChI:  InChI=1S/C10H15N5O2/c1-2-7(3-16)17-6-15-5-14-8-9(11)12-4-13-10(8)15/h4-5,7,16H,2-3,6H2,1H3,(H2,11,12,13)

Standard InChI Key:  QJXCNFGHYLBSTA-UHFFFAOYSA-N

Associated Targets(Human)

ATH-8 cell line 300 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 237.26Molecular Weight (Monoisotopic): 237.1226AlogP: 0.15#Rotatable Bonds: 5
Polar Surface Area: 99.08Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.98CX LogP: 0.00CX LogD: 0.00
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.77Np Likeness Score: 0.18

References

1. Abushanab E, Sarma MS..  (1989)  1',2'-seco-dideoxynucleosides as potential anti-HIV agents.,  32  (1): [PMID:2909746] [10.1021/jm00121a016]

Source